J Korean Med Assoc.  2012 Dec;55(12):1171-1177. 10.5124/jkma.2012.55.12.1171.

Current status of end-of-life care in Korean hospitals

• Koh Y

• KMID: 2015661
• DOI: http://doi.org/10.5124/jkma.2012.55.12.1171

Abstract

The level of end-of-life (EOL) care quality in the Republic of Korea has been regarded as inferior to more advanced countries. The EOL care delivered has varied depending on physicians' perceptions and patients' family requests for care. A consensus guideline on withdrawing life-sustaining therapies, which has been endorsed by the Korean Medical Association, Korean Academy of Medical Sciences, and Korean Hospital Association, was published on 13 October 2009. However, the guideline seems to be still not widely applied in our hospitals. The acknowledgment of patient wish, reflected by such as an advance directives (AD) is the most important ethical and legal requirement in EOL care decisions. However, there are barriers to adopting the AD as a solely legitimate tool of EOL decision making even in Western societies. Advance care planning depending on a patient's condition seems to be a more reasonable approach for better EOL care. For an appropriate advance care planning, open communications between physicians and patients or their surrogates is crucial. The lack of an open approach to discussing EOL care with patients results in inappropriate prolongation of patients' dying process. In summary, physicians, who know the clinical signficance of treatments to be delivered to EOL patients, should play a central role based on the 2009 consensus guideline to help patients and their families make good decisions on EOL care. EOL care should be individualized to meet a patient's and family's wishes about the forgoing of life-sustaining therapy. Moreover, concerted actions between the public sector and a governmental organization are required to address ongoing public demands for better EOL care. social requests.

Keyword

Guideline; Terminal care; Personal autonomy; Withholding treatment

MeSH Terms

Advance Care Planning
Advance Directives
Consensus
Decision Making
Humans
Personal Autonomy
Public Sector
Republic of Korea
Terminal Care
Withholding Treatment

Reference

1. Angus DC, Barnato AE, Linde-Zwirble WT, Weissfeld LA, Watson RS, Rickert T, Rubenfeld GD. Robert Wood Johnson Foundation ICU End-Of-Life Peer Group. Use of intensive care at the end of life in the United States: an epidemiologic study. Crit Care Med. 2004. 32:638–643.

2. Truog RD. End-of-life decision-making in the United States. Eur J Anaesthesiol Suppl. 2008. 42:43–50.

3. Azoulay E. The end-of-life family conference: communication empowers. Am J Respir Crit Care Med. 2005. 171:803–804.

4. Pochard F, Darmon M, Fassier T, Bollaert PE, Cheval C, Coloigner M, Merouani A, Moulront S, Pigne E, Pingat J, Zahar JR, Schlemmer B, Azoulay E. French FAMIREA study group. Symptoms of anxiety and depression in family members of intensive care unit patients before discharge or death. A prospective multicenter study. J Crit Care. 2005. 20:90–96.

5. Kwon I, Koh Y, Yun YH, Heo DS, Seo SY, Kim H, Choi K, Bae H, Ahn K. A study of the attitudes of patients, family members, and physicians toward the withdrawal of medical treatment for terminal patients in Korea. Korean J Med Ethics. 2010. 13:1–16.

6. Downey L, Au DH, Curtis JR, Engelberg RA. Life-sustaining treatment preferences: matches and mismatches between patients' preferences and clinicians' perceptions. J Pain Symptom Manage. 2012. 09. 24. [Epub]. DOI: 10.1016/j.jpainsymman.2012.07.002.

7. The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA. 1995. 274:1591–1598.

8. Prendergast TJ, Claessens MT, Luce JM. A national survey of end-of-life care for critically ill patients. Am J Respir Crit Care Med. 1998. 158:1163–1167.

9. Bae JM, Gong JY, Lee JR, Heo DS, Koh Y. A survey of patients who were admitted for life-sustaining therapy in nationwide medical institutions. Korean J Crit Care Med. 2010. 25:16–20.

10. Morris JN, Suissa S, Sherwood S, Wright SM, Greer D. Last days: a study of the quality of life of terminally ill cancer patients. J Chronic Dis. 1986. 39:47–62.

11. Fox E, Landrum-McNiff K, Zhong Z, Dawson NV, Wu AW, Lynn J. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUPPORT Investigators. Study to understand prognoses and preferences for outcomes and risks of treatments. JAMA. 1999. 282:1638–1645.

12. Sprung CL, Cohen SL, Sjokvist P, Baras M, Bulow HH, Hovilehto S, Ledoux D, Lippert A, Maia P, Phelan D, Schobersberger W, Wennberg E, Woodcock T. Ethicus Study Group. End-of-life practices in European intensive care units: the Ethicus Study. JAMA. 2003. 290:790–797.

13. Heo DS. Patient autonomy and advance directives in Korea. J Korean Med Assoc. 2009. 52:865–870.

14. Yun YH, Lee MK, Chang YJ, You CH, Kim S, Choi JS, Lim HY, Lee CG, Choi YS, Hong YS, Kim SY, Heo DS, Jeong HS. The life-sustaining treatments among cancer patients at end of life and the caregiver's experience and perspectives. Support Care Cancer. 2010. 18:189–196.

15. Camhi SL, Mercado AF, Morrison RS, Du Q, Platt DM, August GI, Nelson JE. Deciding in the dark: advance directives and continuation of treatment in chronic critical illness. Crit Care Med. 2009. 37:919–925.

16. Kierner KA, Hladschik-Kermer B, Gartner V, Watzke HH. Attitudes of patients with malignancies towards completion of advance directives. Support Care Cancer. 2010. 18:367–372.

17. Quill TE. Perspectives on care at the close of life. Initiating end-of-life discussions with seriously ill patients: addressing the "elephant in the room". JAMA. 2000. 284:2502–2507.

18. Azoulay E, Pochard F, Chevret S, Adrie C, Annane D, Bleichner G, Bornstain C, Bouffard Y, Cohen Y, Feissel M, Goldgran-Toledano D, Guitton C, Hayon J, Iglesias E, Joly LM, Jourdain M, Laplace C, Lebert C, Pingat J, Poisson C, Renault A, Sanchez O, Selcer D, Timsit JF, Le Gall JR, Schlemmer B. FAMIREA Study Group. Half the family members of intensive care unit patients do not want to share in the decision-making process: a study in 78 French intensive care units. Crit Care Med. 2004. 32:1832–1838.

19. Van Asselt D. Advance directives: prerequisites and usefulness. Z Gerontol Geriatr. 2006. 39:371–375.

20. Sun DS, Chun YJ, Lee JH, Gil SH, Shim BY, Lee OK, Jung IS, Kim HK. Recognition of advance directives by advanced cancer patients and medical doctors in hospice care ward. Korean J Hosp Palliat Care. 2009. 12:20–26.

21. Azoulay E, Metnitz B, Sprung CL, Timsit JF, Lemaire F, Bauer P, Schlemmer B, Moreno R, Metnitz P. SAPS 3 investigators. End-of-life practices in 282 intensive care units: data from the SAPS 3 database. Intensive Care Med. 2009. 35:623–630.

22. Song T, Kim K, Koh Y. Factors determining the establishment of DNR orders in oncologic patients at a university hospital in Korea. Korean J Med. 2008. 74:403–410.

23. Lee K, Jang HJ, Hong SB, Lim CM, Koh Y. Do-not-resuscitate order in patients, who were deceased in a medical intensive care unit of an university hospital in Korea. Korean J Crit Care Med. 2008. 23:84–89.

24. Fassier T, Lautrette A, Ciroldi M, Azoulay E. Care at the end of life in critically ill patients: the European perspective. Curr Opin Crit Care. 2005. 11:616–623.

25. Schneiderman LJ, Gilmer T, Teetzel HD, Dugan DO, Blustein J, Cranford R, Briggs KB, Komatsu GI, Goodman-Crews P, Cohn F, Young EW. Effect of ethics consultations on nonbeneficial life-sustaining treatments in the intensive care setting: a randomized controlled trial. JAMA. 2003. 290:1166–1172.

26. Koh Y, Meng K, Koo YM, Sohn M, Hwang SI, Hong CD. Hospital ethics committees in Korea. Korean J Med Ethics Educ. 1999. 2:63–78.

27. Koh Y, Heo DS, Yun YH, Moon JL, Park HW, Choung JT, Jung HS, Byun BJ, Lee YS. Charactersitics and issues of guideline to withdrawal of a life-sustaining therapy. J Korean Med Assoc. 2011. 54:747–757.

28. Moon JY, Lim CM, Koh Y. The level of awareness among Korean physicians of the consensus guidelines to withhold or withdraw life-sustaining therapies. Korean J Med Ethics. 2011. 14:266–275.

29. Christakis NA, Iwashyna TJ. Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med. 1998. 158:2389–2395.

30. Schneiderman LJ, Jecker NS, Jonsen AR. Medical futility: its meaning and ethical implications. Ann Intern Med. 1990. 112:949–954.

31. Task Force on Ethics of the Society of Critical Care Medicine. Consensus report on the ethics of foregoing life-sustaining treatments in the critically ill. Crit Care Med. 1990. 18:1435–1439.

32. Medical futility in end-of-life care: report of the Council on Ethical and Judicial Affairs. JAMA. 1999. 281:937–941.

33. Lautrette A, Peigne V, Watts J, Souweine B, Azoulay E. Surrogate decision makers for incompetent ICU patients: a European perspective. Curr Opin Crit Care. 2008. 14:714–719.

34. Kim DY. Medications at the end of life care for terminal cancer patients during their last admission. Korean J Hosp Palliat Care. 2010. 13:7–12.